The FDA announced on March 6, 2015, that Hospira Inc. is recalling Magnesium Sulfate Injection due to a labeling error where units may be mislabeled with an incorrect barcode scanning as heparin sodium. The agency classified the recall as Class I.
How to tell if you have it
- Brand: Hospira
- Product: MAGNESIUM SULFATE IN 5% DEXTROSE INJECTION, USP, 10 mg/mL; 100 mL bag
- NDC: 0409-6727-23
- UPC: (01) 0 030409 672723 1.
- Lot: 42-120-JT
- Expiration: Exp 01DEC2015
- Quantity: 181,704 bags
The hazard
The hazard involves a potential for some units to be mislabeled with an incorrect barcode on the immediate container that scans as heparin sodium 2000 USP units/1000 mL in 0.9% in sodium chloride injection.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Amneal Magnesium Sulfate IV Bags Contain Wrong Drug (March 18, 2026) and Golden State Medical Recalls Prasugrel HCl 10mg Tablets (August 21, 2026).